COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office

BACKGROUND: Following the authorization and recommendations for use of the U.S. COVID-19 vaccines, the Centers for Disease Control and Prevention (CDC)’s Immunization Safety Office (ISO) responded to inquiries and questions from public health officials, healthcare providers, and the general public o...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Elaine R., Moro, Pedro L., Shimabukuro, Tom T., Carlock, Grace, Davis, Shaeyla N., Freeborn, Emma M., Roberts, Amy L., Gee, Julianne, Taylor, Allan W., Gallego, Ruth, Suragh, Tiffany, Su, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208263/
https://www.ncbi.nlm.nih.gov/pubmed/37248099
http://dx.doi.org/10.1016/j.vaccine.2023.05.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208263/
https://www.ncbi.nlm.nih.gov/pubmed/37248099
http://dx.doi.org/10.1016/j.vaccine.2023.05.054

Ejemplares similares